Stockscreener 앱 받기
1.69
4.52%
-0.08
시간 외 거래:
1.69
전일 마감가:
$1.77
열려 있는:
$1.76
하루 거래량:
482.10K
Relative Volume:
0.22
시가총액:
$157.96M
수익:
$34.48M
순이익/손실:
$-102.07M
주가수익비율:
-1.1575
EPS:
-1.46
순현금흐름:
$-104.90M
1주 성능:
+6.29%
1개월 성능:
-10.58%
6개월 성능:
+5.62%
1년 성능:
-1.74%
1일 변동 폭
$1.68
$1.765
1주일 범위
$1.54
$1.80
52주 변동 폭
$0.66
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
명칭
Caribou Biosciences Inc
전화
510-982-6030
주소
2929 7TH STREET, SUITE 105, BERKELEY
CRBU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.69 | 165.44M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-11-08 | 개시 | Cantor Fitzgerald | Neutral |
| 2023-10-31 | 개시 | Evercore ISI | Outperform |
| 2023-07-11 | 개시 | Truist | Buy |
| 2022-02-18 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-01 | 개시 | Oppenheimer | Outperform |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-11-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-08-17 | 개시 | BofA Securities | Buy |
| 2021-08-17 | 개시 | Citigroup | Neutral |
| 2021-08-17 | 개시 | SVB Leerink | Outperform |
모두보기
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
Why Caribou Biosciences Inc. stock is rated strong buy2025 Risk Factors & Expert Approved Momentum Trade Ideas - ulpravda.ru
How sustainable is Caribou Biosciences Inc. stock dividend payoutShort Interest Overview & Superior Growth Investment - bollywoodhelpline.com
How Caribou Biosciences Inc. stock trades before earningsPortfolio Return Report & AI Based Trade Execution Alerts - ulpravda.ru
Can Caribou Biosciences Inc. stock sustain revenue growthM&A Rumor & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Income Plays: How analysts rate Caribou Biosciences Inc. stock todayMarket Risk Summary & High Conviction Buy Zone Picks - ulpravda.ru
What is the fair value of Caribou Biosciences Inc. stock nowGeopolitical Risk Analysis & Missed Nvidia? Don’t Miss This One - ulpravda.ru
Can Caribou Biosciences Inc. stock continue upward trendMean Reversion Trades & Big Gains Low Budget - ulpravda.ru
Aug Intraday: Can Caribou Biosciences Inc stock sustain revenue growthMarket Weekly Review & Daily Volume Surge Trade Alerts - moha.gov.vn
Caribou Biosciences (CRBU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Caribou Biosciences Inc stock remain a Wall Street favoriteGold Moves & Low Risk Entry Point Guides - moha.gov.vn
What valuation multiples suggest for Caribou Biosciences Inc. stockGap Fill Strategies & Affordable Growth Investments - bollywoodhelpline.com
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
Caribou Biosciences (NASDAQ:CRBU) Trading Up 2.4%Should You Buy? - MarketBeat
Why Caribou Biosciences Inc. stock is popular among millennialsJuly 2025 News Drivers & Weekly Momentum Picks - Улправда
Would You Still Hold Caribou Biosciences Stock If It Fell Another 30%? - Trefis
Will Caribou Biosciences Inc. stock benefit from automationWeekly Market Outlook & Low Risk High Reward Trade Ideas - Bölüm Sonu Canavarı
How analysts rate Caribou Biosciences Inc. stock today2025 Short Interest & Accurate Entry and Exit Point Alerts - DonanımHaber
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Published on: 2025-12-19 16:09:33 - Улправда
Can Caribou Biosciences Inc. stock sustain institutional interestJuly 2025 Setups & Smart Swing Trading Alerts - DonanımHaber
How risky is Caribou Biosciences Inc. stock nowQuarterly Market Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Wall Street Recap: Why hedge funds are buying Caribou Biosciences Inc. stock2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Targets Report: How sustainable is Caribou Biosciences Inc. stock dividend payoutWeekly Trade Report & Real-Time Volume Trigger Notifications - Улправда
Will Caribou Biosciences Inc. stock remain a Wall Street favoriteM&A Rumor & Reliable Entry Point Alerts - Улправда
Published on: 2025-12-19 08:19:09 - Улправда
Published on: 2025-12-19 00:46:22 - Улправда
What analyst consensus says on Caribou Biosciences Inc. stockJuly 2025 Action & High Accuracy Buy Signal Tips - Улправда
Market Overview: Why Caribou Biosciences Inc. stock is a value investor pickJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - Улправда
Chart Watch: How risky is Caribou Biosciences Inc stock nowWeekly Trade Review & AI Enhanced Trading Alerts - moha.gov.vn
Caribou Biosciences Earnings Notes - Trefis
Published on: 2025-12-14 05:29:10 - earlytimes.in
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Will Caribou Biosciences Inc. stock reach Wall Street targets2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Caribou Biosciences Target of Unusually Large Options Trading (NASDAQ:CRBU) - MarketBeat
Caribou Biosciences to Host Expert Panel on Access Expansion for vispa-cel CAR-T Therapy at ASH Annual Meeting - Quiver Quantitative
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - 富途牛牛
MACD Signal: Will ABEV stock outperform value stocksJuly 2025 Earnings & Accurate Intraday Trading Signals - BỘ NỘI VỤ
Earnings Risk: What analyst consensus says on Caribou Biosciences Inc stockJuly 2025 Pullbacks & Free Daily Entry Point Trade Alerts - BỘ NỘI VỤ
Caribou Biosciences CEO to address Evercore Healthcare Conference - Traders Union
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Caribou Biosciences, Inc. $CRBU Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Caribou Biosciences signals access challenge in CAR-T cell therapy - Traders Union
Analyzing Caribou Biosciences Inc. with multi timeframe chartsJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Is Caribou Biosciences Inc. stock positioned well for digital economyJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Caribou Biosciences Inc. (CRBU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Caribou Biosciences Inc (CRBU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
4.56%
자본화:
|
볼륨(24시간):